FPJ Edit: Now that the Phase III interim data is out, speed up Covaxin rollout
FPJ Edit: Now that the Phase III interim data is out, speed up Covaxin rollout Speed up the rollout The findings of the first interim analysis of the Phase III clinical trials of Bharat Biotechâs Covaxin have come as a shot in the arm â literally â for both Indian scientists and the governmentâs efforts to vaccinate the vulnerable part of the population. The finding that the India-developed vaccine has an efficacy level of 80.6 per cent, is actually higher than the Oxford University-Astra Zeneca-developed Covishield, which has already been approved and rolled out for us...
Source: freepressjournal.in